Anupam Rasayan India Limited (ARIL) has issued a clarification regarding a news report speculating about the company's plan to acquire a stake in Bliss GVS Pharma Ltd. The company stated that there is no such material event or information that requires disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. ARIL further clarified that they do not wish to comment on such speculations appearing in the news report. The company affirmed its commitment to complying with relevant disclosure norms under SEBI LODR Regulations as per its policy on disclosure of material events and information whenever required. The clarification was issued on February 13, 2026, in response to media reports.
